Prevention of pressure ulcers with a static air support surface : a systematic review by Serraes, Brecht et al.
OR I G I NA L ART I C L E
Prevention of pressure ulcers with a static air support surface:
A systematic review
Brecht Serraes1 | Martin van Leen2,3 | Jos Schols4 | Ann Van Hecke5 | Sofie Verhaeghe5 |
Dimitri Beeckman5
1Department of Nursing, General Hospital, Sint-
Niklaas, Belgium
2Martin’s Geriatric & Wound Consultancy,
Rotterdam, the Netherlands
3Faculty of Health, Medicine and Life Sciences,
Department of Family Medicine, Maastricht
University, Maastricht, Netherlands
4CAPHRI, Care and Public Health Research
Institute, Department of Health Services Research
and Department of Family Medicine, Maastricht
University, Maastricht, Netherlands
5Department of Public Health, University Centre
for Nursing and Midwifery, Ghent University,
Ghent, Belgium
Correspondence
B Serraes MSc, RN, Critical care nurse, Staff
member, AZ Nikolaas, Campus SM,
Moerlandstraat 1, B-9100 Sint-Niklaas, Belgium.
Email: brechtserraes@hotmail.be
D Beeckman PhD, RN, Professor, University
Centre for Nursing and Midwifery, UZ Gent, 5K3,
De Pintelaan 185, B-9000 Gent, Belgium.
Email: dimitri.beeckman@ugent.be
The aims of this study were to identify, assess, and summarise available evidence
about the effectiveness of static air mattress overlays to prevent pressure ulcers.
The primary outcome was the incidence of pressure ulcers. Secondary outcomes
included costs and patient comfort. This study was a systematic review. Six elec-
tronic databases were consulted: Cochrane Library, EMBASE, PubMed
(Medline), CINAHL (EBSCOhost interface), Science direct, and Web of Science.
In addition, a hand search through reviews, conference proceedings, and the refer-
ence lists of the included studies was performed to identify additional studies.
Potential studies were reviewed and assessed by 2 independent authors based on
the title and abstract. Decisions regarding inclusion or exclusion of the studies
were based on a consensus between the authors. Studies were included if the fol-
lowing criteria were met: reporting an original study; the outcome was the inci-
dence of pressure ulcer categories I to IV when using a static air mattress overlay
and/or in comparison with other pressure-redistribution device(s); and studies pub-
lished in English, French, and Dutch. No limitation was set on study setting,
design, and date of publication. The methodological quality assessment was evalu-
ated using the Critical Appraisal Skills Program Tool. Results were reported in a
descriptive way to reflect the exploratory nature of the review. The searches
included 13 studies: randomised controlled trials (n = 11) and cohort studies
(n = 2). The mean pressure ulcer incidence figures found in the different settings
were, respectively, 7.8% pressure ulcers of categories II to IV in nursing homes,
9.06% pressure ulcers of categories I to IV in intensive care settings, and 12%
pressure ulcers of categories I to IV in orthopaedic wards. Seven comparative
studies reported a lower incidence in the groups of patients on a static air mattress
overlay. Three studies reported a statistical (P < .1) lower incidence compared
with a standard hospital mattress (10 cm thick, density 35 kg/m3), a foam mattress
(15 cm thick), and a viscoelastic foam mattress (15 cm thick). No significant dif-
ference in incidence, purchase costs, and patient comfort was found compared
with dynamic air mattresses. This review focused on the effectiveness of static air
mattress overlays to prevent pressure ulcers. There are indications that these mat-
tress overlays are more effective in preventing pressure ulcers compared with the
use of a standard mattress or a pressure-reducing foam mattress in nursing homes
and intensive care settings. However, interpretation of the evidence should be per-
formed with caution due to the wide variety of methodological and/or reporting
quality levels of the included studies.
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1 | INTRODUCTION
“A pressure ulcer (PU) is defined as a localized injury to
the skin and/or underlying tissue usually over a bony promi-
nence, as a result of pressure, or pressure in combination
with shear. A number of contributing factors are also associ-
ated with pressure ulcer; the significance of these factors is
yet to be elucidated”.1
The presence of PUs is internationally accepted as an
important indicator of the quality of care. Prevention should
include the identification of at-risk patients and the introduc-
tion of preventive interventions tailored to the patient. Pri-
marily, the interventions should focus more on prevention
rather than treatment of PUs.2 The decision to use pressure-
redistributing resources is determined by risk assessment,
patient comfort, general health, training, and the availability
of materials and resources.2,3 International and national
guidelines recommend regular repositioning to prevent
PUs.1,2 Repositioning must be performed in patients with an
increased risk of PUs. The presence of non-blanchable red-
ness indicates that the frequency of repositioning and/or
pressure-redistributing resources is not efficacious.4 Further
research is needed regarding the use of repositioning on dif-
ferent pressure-redistribution support surfaces.
In general, the use of a static air mattress overlay is
lower compared with the alternating pressure mattress.5 In a
study by Serraes and Beeckman6, 31% of the participants
received no specified PU prevention interventions, and 43%
was lying on a viscoelastic foam mattress. A significantly
lower number of participants were lying on an alternating
pressure mattress or a static air mattress overlay—24% and
2% of the participants, respectively.
A Cochrane systematic review defined 3 groups of
pressure-redistribution support surfaces (PRSS): high-
technology support surfaces (electrically powered, alternat-
ing pressure devices), low-technology support surfaces (not
electrically powered, constant low-pressure devices), and
other support surfaces (operating table mattress pad, rotating
beds, cushions, and limb protectors).7 The high-technology
supported surfaces include alternating-pressure mattresses/
overlays, air-fluidised beds, and low-air-loss beds. The high-
technology supported surfaces provide pressure redistribu-
tion by cyclic inflated and deflated air characterised by fre-
quency, duration, amplitude, and rate of change, with or
without the body weight of the patient resting on the sur-
face.8 The low-technology support surfaces include sheep-
skins and mattresses or overlays filled with standard foam,
alternative foam, gel, fibre, air, water, and bead.7
Support surfaces conform to the contours of the body to
spread the load of the patient over a maximum area when a
person lies on the mattress.6,9,10 Pressure redistribution is
based on the principles of envelopment and immersion to
increase contact surface.4 “Envelopment” is the ability of a
support surface to conform (fit or mould) around irregularities
of the body.8 “Immersion” refers to the depth of penetration
or “sinking” into a support surface.8 Envelopment and
immersion are possible with a static air mattress over-
lay.4,11,12 The static air mattress overlay is compact and low
in weight. It consists of several compartments; the air moves
over a large area when a person lies on the mattress.6,9,13,14
Currently, there is no systematic review that specifically
assesses the effectiveness of a static air mattress overlay in
the prevention of PUs.
2 | AIM AND OBJECTIVES
The aim of this systematic review was to identify, assess,
and summarise evidence to prevent the development of PUs
on a static air mattress overlay. One primary outcome
(PU incidence) and 2 secondary outcomes (cost and patient
comfort) were carefully selected to guide the reporting of
the data from the original studies. All data were reported in
a descriptive way. The aim was not to develop broader
statements about effectiveness of the devices because of the
exploratory nature of the review.
3 | METHOD
3.1 | Eligibility criteria, information sources, and
search
A 2-step search strategy was applied to identify relevant
studies. Firstly, 6 electronic databases were systematically
Key Messages
• there is a wide variety of strategies and Pressure-Redistribution
Support Surfaces (PRSS) available for the prevention and treat-
ment of pressure ulcers
• there are 3 main groups of PRSS: (1) high-technology sup-
ported, (2) low-technology supported, and (3) other support
surfaces
• there is a difference in the way pressure redistribution takes
place when using high-technology supported pressure redistri-
bution support surfaces vs low-technology pressure redistri-
bution support surfaces; the static air support surface is a
subgroup of the low-technology PRSS
• this is the first systematic review that evaluated the effective-
ness of static air-filled support surfaces to prevent the devel-
opment of pressure ulcers
• taking into account the methodological and/or reporting qual-
ity issues of the included studies, there are indications that
static air mattress overlays are more effective in preventing
PUs compared with a standard mattress or a pressure-reducing
foam mattress in nursing homes and intensive care settings
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searched: the Cochrane Library, EMBASE, PubMed
(Medline), CINAHL (EBSCOhost interface), Science
Direct, and Web of Science. The terms and synonymies for
PUs, static air mattress overlay, and prevention were com-
bined (see Table 1).
Secondly, a hand search through reviews, conference
proceedings (European Wound Management Association,
European Pressure Ulcer Advisory Panel), and the reference
lists of the included studies was performed to identify addi-
tional studies.
Studies were included if the following criteria were met:
(1) reporting an original study; (2) the outcome was the
incidence of PUs Categories I to IV when using a static air
mattress overlay and/or in comparison with other pressure-
redistribution device(s); and (3) studies published in
English, French, and Dutch. No limitation was set on study
design, date of publication, and patient population. If no full
text could be found, 1 or more authors were contacted by
mail. Studies were excluded if: (1) the support surfaces con-
sidered static air-filled seat cushions and/or heel wedges and
(2) there were insufficient data on primary and secondary
outcomes.
The results of the systematic search were initially
screened on titles and abstracts by researchers. The full texts
of the potential studies were obtained and assessed for
inclusion by 2 independent researchers.
3.2 | Data abstraction and quality appraisal
The included studies were analysed in more detail. A tem-
plate for data extraction was developed, including the fol-
lowing elements: (1) year of publication, (2) design,
(3) sample, (4) setting, (5) primary outcome, (6) secondary
outcome, (7) PU classification system used to assess the
outcomes, and (8) follow-up period of participants (see
Table 3: summary included studies, and Appendix S1 [Sup-
porting information]).
Two researchers independently extracted the data and
performed the quality appraisals of the included studies.
The methodological quality assessment evaluated the risk of
bias using the Critical Appraisal Skills Program (CASP).
The Randomised Control Trail (RCT) CASP tool consists
of 11 questions for a systematic assessment of the quality of
an RCT. The COHORT CASP tool consists of 12 questions
for a systematic assessment of the quality of a Cohort
Study.15 Disagreements regarding the quality assessment
were discussed until consensus was reached. The inter-rater
reliability of the quality assessment between the
2 researchers was calculated using the percentage of agree-
ment and the inter-rater reliability analysis (Cohen’s
kappa, κ).
4 | RESULTS
The systematic search resulted in 925 studies. The hand
search resulted in 10 studies from reference lists of reviews
and conference proceedings. The authors of 2 studies were
contacted; 1 of the authors responded to the request for the
full-text publication. Table 2 reflects the results of the study
selection.
In total, 65 potential studies were included based on the
screening of title and abstract. Based on the inclusion cri-
teria and after excluding duplicates, 52 studies were
excluded (see Figure 1 Flowchart). The reasons for exclu-
sion were irrelevant outcome and insufficient data. The
remaining 13 studies were included for further data extrac-
tion and are shown in Table 3.
The overall agreement for study selection based on title/
abstract between the reviewers was high, and the inter-rater
reliability analysis (Cohen’s kappa, κ) showed an almost
perfect degree of agreement—respectively, 83.9% (n = 26)
and a Cohen’s kappa of 0.832 (P < .001), 95% CI
(0.634, 1.000).
The quality of the 13 studies was assessed. No study
was excluded based on the quality assessments (internal and
external validity). The most important methodological limi-
tations were a lack of information or clarification about
(1) mattress specification (n = 4),16–19 (2) randomisation
method (n = 3),20–22 (3) withdrawals and
dropouts,16–20,22,23 (4) blinding method
(n = 9),13,16,17,19,20,22–26 (5) similar from baseline (n = 6),
and groups treated equally (n = 5) (see Table 4: judgement
about the methodological quality of the studies).
The overall agreement rate and inter-rater reliability
analysis (Cohen’s kappa, κ) for the quality assessments
between researchers was high to almost perfect—
TABLE 1 Search terms used in: PubMed (Medline), Cinahl (EBSCOHOST interface), Science Direct, and Web of Science
Search terms Mesh terms
1. Pressure ulcer (pressure ulcer) OR (ulcers pressure) OR (decubitus) OR (pressure damage) OR (bed sore) OR (bedsores) OR (pressure sore) OR
(pressure sores) OR (scores, pressure)
2. Static air-filled mattress
overlay
(static mattress) OR (static cushion) OR (static overlay) OR (air-filled overlay) OR (air-filled cushion) OR (air cushion) OR (air
mattress) OR (air overlay) OR (low tech overlay) OR (low tech mattress) OR (non-powered mattress) OR (non-powered overlay)
OR (constant low-pressure support mattress) OR (constant low-pressure support surfaces) OR (constant low mattress)
3. Prevention (prevention) OR (primary prevention) OR (preventive therapy) OR (prophylaxis) OR (preventive measures) OR (accident
prevention)
Search strategy 1 AND 2 AND 3. Search term used in Cochrane Library were (“pressure ulcer” AND ”static”). Search term used in Embase were (“pressure ulcer”
AND “static” AND “Prevention”).
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respectively, an overall agreement of 96.7% (n = 117) and
a Cohen’s kappa of 0.905 (P < .001), 95% CI
(0.791, 0.980).
4.1 | Characteristics of the included studies
The main outcome of this review was the incidence of PUs
of categories I to IV when using a static air mattress overlay
and/or in comparison with other pressure-redistribution
device(s) for the prevention of PUs (see Table 5). The data
of the included studies were heterogeneous (see Table 3 and
Appendix S1).
The included studies were RCTs (n = 11) and cohort
studies (n = 2) conducted in nursing homes, intensive care
units, surgical wards, and orthopaedic wards. Sample size
ranged from 16 to 1074 participants. The most used base-
line characteristics were patient age, evaluation of PU at
admission, and risk assessment scales. The age of the
participants ranged from >18 years (n = 3) to >60 years
(n = 1) and >65 years (n = 5). In 4 studies, age was not
reported.
Various risk assessment scales and cut-off points were
used in the included studies: Norton score 5 to 12 (n = 1),
Norton score < 8 (n = 2), Norton score > 15 (n = 1); Bra-
den score 9 to 16 (n = 1), Braden score ≤ 12 (n = 1), Bra-
den score ≤ 14 (n = 1), Braden score ≤ 16 (n = 1), Braden
score < 18 (n = 1); Waterlow score > 15 (n = 1); and
Medley score > 25 (n = 1). Two studies reported no risk
assessment scales. Four studies included participants with
PUs at admission.
There was a variety of classification systems for the
assessment of the skin: European Pressure Ulcers Scale
(EPUAP), National Pressure Ulcers Scale (NPUAP)
(n = 2), Stirling Pressure Score Severity Scale (n = 1),
Grading or Shea (n = 1), formulated own classification sys-
tem different from EPUAP/NPUAP (n = 3), and no
reported classification (n = 2).
In some studies, the static air mattress overlay was
compared with a high-technology supported surface or
compared with another low-technology support surface, a
gel mattress, a water mattress overlay, a (cold) foam mat-
tress, a viscoelastic foam mattress, and a Micro Static
fluid Overlay (MSO) based on foam (see Table 3 and
Appendix S1).
4.2 | Primary outcome: PU incidence
In 6 studies, a static air mattress overlay was compared with
a high-technology supported surface.13,16,18,20,23,26 Two
studies, each in a different setting (hospital hip fracture and
surgical intensive care), reported a lower overall incidence
of PU in the group where the static air mattress overlay was
used.18,20 Another study in a similar orthopaedic ward
(n = 1)13 and studies in intensive care wards (n = 3)
reported a lower incidence of PUs in the group where the
high-technology supported surfaces was used.16,23,26 None
of the included studies found significant differences in the
incidence of PUs between a static air mattress overlay and a
high-technology supported surface in a variety of settings:
intensive care and orthopaedic wards.
In 7 studies, a static air mattress overlay was compared
with another low-technology support surface (not electri-
cally powered, constant low-pressure devices). A study con-
ducted in a nursing home reported a higher incidence of
PUs of categories I to II in the group where a static air mat-
tress overlay was used, compared with a gel mattress,
TABLE 2 Summary of included/excluded studies
Results Cochrane library Embase Pubmed (Medline) Cinahl ScienceDirect Web of Science Hand search
Total 15 173 237 115 297 88 —
Excluded 10 160 219 107 295 79 —
Included 5 13 18 8 2 9 10
Identification
Screening
Eligibility
Included
Records identified through 
database searching
(n = 925)
Additional Records 
identified through hand 
search (n = 10)
Total Records identified through 
searching (n = 935)
Records excluded
(n = 870)
Records screened on 
title/abstract
(n = 935)
Potential records after 
duplicates removed
(n = 31)
Potential records
(n = 65)
Full-text records excluded 
with reasons 
(n = 18)
• Outcome (n = 16)
• Insufficient data (n = 2)
Studies included
(n =13)
Records excluded with 
reasons
• Outcome (n = 34)
(PU prevention and static air seat cushion )
FIGURE 1 Flowchart
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TABLE 4 Judgement about the methodological quality of the studies
Lazzara and
Buschmann,
199117
Sideranko
et al,
199220
Takala
et al,
199621
Cobb
et al,
199716
Cooper
et al,
199825
Price
et al,
199913
Malbrain
et al,
201023
Van
Leen
et al,
201119
Vermette
et al,
201222
Van
Leen
et al,
201324
Jiang
et al,
201426
CASP tool for RCT Y Y Y Y Y Y Y Y Y Y Y
Did the trial address
a clearly focused
issue?
Y Y Y Y Y Y Y Y Y Y Y
Was the assignment
of patients to
treatments
randomised?
Y ? ? Y Y Y Y Y ? Y Y
Were patients, health
workers, and
study personnel
blinded?
? ? Y ? ? N ? N N N N
Were the groups
similar at the start
of the trial?
Y ? Y N Y Y Y ? N ? ?
Aside from the
experimental
intervention, were
the groups treated
equally?
Y ? ? N Y Y N Y Y Y ?
Were all of the
patients who
entered the trial
accounted for at
its conclusion?
N Y N Y N Y N Y Y Y Y
How large was the
treatment effect?
N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A
How precise was the
estimate of the
treatment effect?
N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A
Can the results be
applied in your
context?
Y Y Y Y Y Y Y Y Y Y Y
Were all clinically
important
outcomes
considered?
Y Y Y Y Y Y Y Y Y Y Y
Are the benefits
worth the harms
and costs?
Y Y Y Y Y Y N Y Y Y Y
Rich et al, 201118 Serraes and Beeckman, 20166
CASP Tool for cohort studies Y Y
Did the trial address a clearly focused issue? Y Y
Was the cohort recruited in an acceptable way? Y Y
Was the exposure accurately measured to minimise bias? ? Y
Was the outcome accurately measured to minimise bias? ? Y
Have the authors identified all important confounding factors? ? ?
Have they taken in account of the confounding factors in the design and/or analysis? ? ?
Was the follow up of subjects complete enough? Y Y
Was the follow up of subjects long enough? Y Y
What are the results of this study? N/A N/A
How precise are the results? N/A N/A
Do you believe the results? Y Y
Can the results be applied to the local population? Y Y
Do the results of this study fit with other available evidence? N Y
What are the implications of this study for practice? N/A N/A
Abbreviations: ?, unclear; N, no; N/A, not applicable; Y, yes.
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respectively, 32.2% and 31.7%.17 The other 6 studies con-
ducted in nursing homes, intensive care units, and emer-
gency orthopaedic trauma wards reported a lower PU
incidence rate in the groups where the static air mattress
overlay was used.19–22,24,25 Of these, 3 studies showed a
difference at a significance level of <.1. PU incidence com-
pared with a standard hospital mattress (10 cm thick, den-
sity 35 kg/m3) (P = P < 0.005), a foam mattress (15 cm
thick) (P = 0.088), and a viscoelastic foam mattress (15 cm
thick) (P = 0.087).19,21,24 The studies were conducted in an
intensive care unit and nursing homes (see Table 3 and
Appendix S1). A multicentre cohort study in nursing homes
reported an incidence of 5.1% (n = 9/176) PUs of catego-
ries II to IV.6 This incidence figure is similar to other
studies.18–22,24 The mean PU incidence figures found in the
different settings was 7.8% PUs of categories II to IV in
nursing homes,6,17,19,24 9.06% PUs of categories I to IV in
intensive care settings,16,20–23,26 and 12% PUs of categories
I to IV in orthopaedic wards.13,18,25
4.3 | Secondary outcomes
In this review, secondary outcome measures of cost (n = 3)
and patient comfort (n = 4) were included (see Table 3).
4.3.1 | Cost
The costs of static air mattress overlays was less expensive
compared with high-technology supported surfaces in the
prevention and treatment of PUs.13,16,22 Price et al (1999)
reported that the costs of a static air mattress overlay for
single-patient use would be less than £5000, which was a
difference of 50% when using a dynamic support mattress
in the prevention of PUs. Vermette et al22 found that the
static air mattress overlays were less expensive in total costs
compared with the MSO and low-air-loss dynamic mattress,
respectively, $3364 CAD vs $13 606 CAD (P = .001).
Cobb et al16 found a significant difference of $ 59 000 in
rental fees (P = .017) compared with the costs of the low-
air-loss mattress. Overall, there was a wide variety in the
approach of the cost.
4.3.2 | Patient comfort
Comfort of the patient was evaluated using a 5-point rating
scale.22,25,26 No significant difference in comfort rating was
reported. One study reported a higher comfort level when
using a static air mattress overlay compared with a dynamic
support mattress.13
5 | DISCUSSION
The aim of this review was to identify, assess, and summa-
rise available evidence about the effectiveness of static air
mattress overlays to prevent PUs. Generating broader state-
ments about the effectiveness of these devices was not pos-
sible because of large heterogeneity in study designs,
outcome reporting, surfaces being tested, and methodologi-
cal limitations. The primary outcome of this review was the
incidence of PUs of categories I to IV, and the data were
reported in a descriptive way to reflect the exploratory
nature of the review. Based on the included studies, a static
air support surfaces appeared to be more effective compared
with a standard mattress and pressure-reducing foam mat-
tress. However, the studies comparing the effectiveness of
static air support surfaces with high-technology support sur-
faces reported inconsistent evidence. It is not possible to
conclude which support surface is superior. Overall, we
found varying figures of mean PU incidence in a variety of
settings: 7.8% PUs of categories II to IV in nursing homes,
9.06% PUs of categories I to IV in intensive care settings,
and 12% PUs of categories I to IV in orthopaedic wards.
We could not conclude that a static air support surface is
more or less effective than other support surfaces in a vari-
ety of settings.
Secondary outcomes focused on costs and patient com-
fort. The costs of static air mattress overlays were lower
compared with high-technology supported surfaces.13,16,22
However, cost data were not always or were inconsequently
reported in the primary studies. There was a wide variety in
the methods used to collect cost data. One study compared
rental fees with purchasing costs of the support surfaces.16
No formal economic model was designed because of the
lack of information and the heterogeneity about economic
data in the included studies. Further research should focus
on performing and reporting economic data based on inter-
national guidelines. Patient comfort was evaluated in 4 stud-
ies.13,22,25,26 Only 1 study reported a higher comfort level
when using a static air mattress overlay compared with a
dynamic support mattress. However, the method to evaluate
the comfort was not clearly described.13 The incidence of
PUs should be a primary outcome, but cost and especially
patient comfort are also relevant and must be taken into
account. All 3 measures provide important information for
policymakers for decision making about purchasing support
surfaces for their organisation. Therefore, further research is
recommended on the cost-effectiveness and patient comfort
TABLE 5 Specification static air mattress overlay
Specification mattress overlay Studies (n) References
EHOB Waffle static air mattress overlay 4 16,19,22,26
Repose low-pressure inflatable mattress 3 6,13,24
ROHO reactive mattress overlay 2 23,25
SOFFLEX mattress: similar to the ROHO
mattress but consists of lager cells and
therefore requires only 3 sections to make a
full mattress
1 25
Sof Care air-filled overlay 1 17
Gay Mar Sof Care static air 1 20
Carital air-float system 1 21
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of the static air mattress overlay in the prevention and/or
treatment of PUs in patients in different health care settings.
5.1 | Limitations
The methodological quality of the studies was assessed using
the CASP. Because of the exploratory character of the review,
the authors decided not to exclude studies based on methodo-
logical quality. The CASP evaluation revealed that major
issues remained at the level of blinding, reporting of compara-
bility of study groups, reporting about confounding factors,
follow up, and analyses. No differences were seen when we
evaluated the quality of the reporting over time. Many
resources are invested in designing clinical studies, with only
limited contribution to the scientific community and clinical
practice. The results of this review should be interpreted with
caution and should take into account the wide variety of meth-
odological and/or reporting quality of the included studies.
Core outcome sets (COS) for guiding the design of clinical
studies and reporting of the results are currently widely being
developed. The field of PUs will clearly benefit from the exis-
tence of such a COS. The use of valid outcomes and instru-
ments to measure them in a reliable way will benefit the
reporting and will reduce the heterogeneity of outcome selec-
tion. This will allow authors of systematic reviews to pool
non-heterogeneous data into meta-analyses and to generate
broader statements on the relative effectiveness of the different
surfaces. This was not possible in this systematic review.
5.2 | Implications for clinical practice and future
research
The evidence about static air support surfaces is limited.
Results suggest that these support surfaces are more effec-
tive compared with a standard mattress or a pressure-
reducing foam mattress in nursing homes and intensive care
settings. However, evidence should be treated with caution.
In a variety of settings, no support surface was found to be
superior in effectiveness and in comfort for patients. No sig-
nificant difference in purchase costs was found compared
with dynamic air mattresses. The results of the studies indi-
cated that the static air support surface was less expensive
compared with the high-technology mattresses.
The selection of the best support surface for each indi-
vidual patient involves various factors and is, therefore,
quite complex. The decision to use pressure-redistributing
resources is determined by the risk assessment, patient com-
fort, general health, training, and the availability of mate-
rials and resources.2,3
Independent, well-designed, multicentre RCTs are
recommended to assess the efficacy and cost-effectiveness
of static air support surfaces in the prevention and treatment
of PUs in a variety of settings. Studies with a clear and
transparent methodology (clinical setting, clearly described
baseline characteristics, inclusion and exclusion criteria,
adequate follow-up period, use of a risk assessment scale,
an international PU classification system, a repositioning
protocol, clear definition of the study mattresses, clearly
described randomisation, dropouts, missing data, and data
analysis) are essential. Researchers should take into account
the limitations of previous studies when designing new
research. Unfortunately, several limitations were similar
between the included studies.
6 | CONCLUSION
This review focused on the effectiveness of static air mattress
overlays to prevent PUs. There are indications that these mat-
tress overlays are more effective in preventing PUs compared
with a standard mattress or a pressure-reducing foam mattress
in nursing homes and intensive care setting. No studies
reported significant differences in effectiveness, patient com-
fort, and purchase costs between a static air mattress overlay
compared with a high-technology mattress. However, the
available evidence should be treated with caution due the wide
variety of methodological and/or reporting quality levels of the
included studies. Study quality is a major issue as many
resources are invested in designing clinical studies, with lim-
ited contribution to the scientific community and clinical
practice.
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